Daratumumab in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma and Severe Renal Impairment
Clinical trial NCT02977494 · COMPLETED
Trial details
- NCT number
- NCT02977494
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2021-06-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.